Beam Therapeutics to Participate in Upcoming September Investor Conferences
31 Août 2023 - 12:30PM
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company
developing precision genetic medicines through base editing, today
announced that management plans to participate in fireside chats
during the following September investor conferences:
- Citi’s 18th Annual BioPharma Conference 2023 on Thursday,
September 7, 2023 at 8:50 a.m. ET in Boston;
- 2023 Wells Fargo Securities Healthcare Conference on Thursday,
September 7, 2023 at 10:15 a.m. ET in Boston; and,
- BMO BioPharma Virtual Spotlight Series: Gene Editing and
Therapy on Tuesday, September 26, 2023 at 10:00 a.m. ET.
Live webcasts will be available in the investor section of the
company's website at www.beamtx.com, and will be archived for 60
days following the presentation.
About Beam TherapeuticsBeam Therapeutics
(Nasdaq: BEAM) is a biotechnology company committed to establishing
the leading, fully integrated platform for precision genetic
medicines. To achieve this vision, Beam has assembled a platform
that includes a suite of gene editing and delivery technologies and
is in the process of building internal manufacturing capabilities.
Beam’s suite of gene editing technologies is anchored by base
editing, a proprietary technology that is designed to enable
precise, predictable and efficient single base changes, at targeted
genomic sequences, without making double-stranded breaks in the
DNA. This has the potential to enable a wide range of therapeutic
editing strategies that Beam is using to advance a diversified
portfolio of base editing programs. Beam is a values-driven
organization committed to its people, cutting-edge science, and a
vision of providing life-long cures to patients suffering from
serious diseases.
Contacts:
Investors:Holly ManningTHRUST Strategic
Communicationsholly@thrustsc.com
Media:Dan Budwick1ABdan@1abmedia.com
Beam Therapeutics (NASDAQ:BEAM)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Beam Therapeutics (NASDAQ:BEAM)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024